ARMT
ADMA icon

Amica Retiree Medical Trust’s ADMA Biologics ADMA Stock Holding History

Amica Retiree Medical Trust’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$16K Hold
1,069
– – 0.02% 138
2025
Q2 		$19K Hold
1,069
– – 0.03% 132
2025
Q1 		$21K Sell
1,069
-191
-15% -$3.3K 0.03% 130
2024
Q4 		$22K Buy
+1,260
New +$23.7K 0.02% 132

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Amica Retiree Medical Trust's ADMA Position: Q3 2025 in Review

Amica Retiree Medical Trust held its ADMA Biologics (ADMA) position steady in Q3 2025 at 1,069 shares worth $16K. The position accounts for 0.02% of the portfolio, ranked #138.

Amica Retiree Medical Trust first reported a position in ADMA in Q4 2024 and has held it in 4 quarters since. The position peaked at $22K in Q4 2024. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

  • Amica Retiree Medical Trust held 1,069 shares of ADMA Biologics worth $16K as of Q3 2025.
  • Amica Retiree Medical Trust left its ADMA Biologics share count unchanged in Q3 2025.
  • ADMA Biologics made up 0.02% of Amica Retiree Medical Trust's portfolio in Q3 2025, its #138 holding.
  • Amica Retiree Medical Trust first reported a position in ADMA Biologics in Q4 2024 and has held it in 4 quarters since.
  • Amica Retiree Medical Trust's ADMA Biologics position peaked at $22K in Q4 2024.
  • 365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on Amica Retiree Medical Trust's 13F filing for Q3 2025, filed 7 Nov 2025.